Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997.

Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997. J Clin Oncol. 2007 Mar 01; 25(7):799-804.

View in: PubMed

subject areas

ADP-ribosyl Cyclase 1
Adult
Aged
Aged, 80 and over
Apoptosis
Chromosome Aberrations
Female
Genes, p53
Humans
Immunoglobulin Heavy Chains
Immunoglobulin Variable Region
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Middle Aged
Mutation
Prospective Studies
ZAP-70 Protein-Tyrosine Kinase

authors with profiles

Richard A. Larson